Aberrant AR signaling pathways promote prostate tumorigenesis (68), and because COPI coatomers modulated AR transcriptional activity in prostate tumor cells (Fig. 12A), we wanted to determine COPI coatomer expression across normal prostate tissue, localized prostate cancers, and metastatic prostate cancers. Here, AR is linked to metastatic prostate carcinoma.